Olema Pharmaceuticals inc (NAS:OLMA)
$ 11.54 -1.18 (-9.28%) Market Cap: 660.85 Mil Enterprise Value: 490.71 Mil PE Ratio: 0 PB Ratio: 2.91 GF Score: 38/100

Olema Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 02:40PM GMT
Release Date Price: $12.38 (+6.08%)
Albert Wong
Morgan Stanley - Analyst

Good morning, everybody, and thank you for attending the Olema fireside chat. My name is [Albert Wong], I'm a Managing Director, and I run the US health care business on the investment banking side. With me, I have Shane Kovacs, who's the CFO of Olema. And I'll let Shane introduce himself before we get into the questions.

Shane Kovacs
Olema Pharmaceuticals, Inc. - Chief Operating and Financial Officer

Great. Well, thanks for hosting us today. It's a real pleasure to be at the Morgan Stanley Conference, and I've got a great deal of investor meetings today, so I appreciate it. I'm Shane Kovacs, I'm the Chief Operating and Financial Officer at Olema. I've been here about a little over three years. I used to be on the banking side a long time ago and have been in operating roles for last 10 years or so. Super excited about what's going on at Olema and happy to update you guys as part of the conference.

Questions & Answers

Albert Wong
Morgan Stanley - Analyst

So maybe we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot